New Limit
A biotech company focused on longevity research through epigenetic reprogramming to restore cellular function.
Recently discussed in
What creators say
"Brian Armstrong from Coinbase, the CEO, started one called New Limit, and they've got a lot of money — all billions."
More from David Sinclair →
"There are no fewer than six companies currently working on partial epigenetic reprogramming. We have Life Biosciences who've dosed the first living humans. New Limit backed by Brian Armstrong. Retro backed by Sam Altman. Altos Labs backed by Jeff ..."
More from Peter Diamandis →+1 more mention from Peter
"New Limit, co-founded by Brian and also by Blake Briars, just raised $435 million and hitting a valuation of $3.1 billion."
"So, at New Limit, we're trying to do half of what Shinya Yamanaka did. We don't want to change the type of the cell, we just want to change the age. We've actually been able to demonstrate successful reprogramming of human cells now in our first d..."
More from Brian Armstrong →+2 more mentions from Brian
"Created this company. It's called New Limit. and it's a longevity company searching for novel therapies that can reprogram your cells to restore fu..."
"there's the fundamental science behind it is called epigenetic reprogramming. It's sort of you can reprogram your cells to restore function they ha..."
"Now we're investors in New Limit which is Blake Byers and Brian Armstrong's company."
More from Bill Maris →Keep exploring
Topics
About this data
- ✓44,000+ mentions extracted from real podcast transcripts
- ✓Every quote links to the source episode
- ✓Sponsored mentions are always labeled
- ✓Critical takes are shown, never filtered out